Optimizing Heart Failure Medications

This chapter explores the key medications for heart failure with reduced ejection fraction, emphasizing guideline-directed therapies like ARNI, beta blockers, MRAs, and SGLT2 inhibitors. The speakers discuss the nuances of medication selection and the impact on patient outcomes and trust, highlighting the importance of tailored treatment plans.